Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2000 | 09-1999 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,625 | N/A |
| Receivables | 30 | N/A |
| TOTAL | $1,655 | $0 |
| Non-Current Assets | ||
| PPE Net | 3,445 | N/A |
| TOTAL | $3,445 | $0 |
| Total Assets | $5,100 | $0 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 191 | N/A |
| TOTAL | $191 | $0 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $0 |
| Total Liabilities | $191 | $0 |
| Shareholders' Equity | ||
| Common Shares | 8,209 | N/A |
| Retained earnings | -3,300 | N/A |
| TOTAL | $4,909 | $0 |
| Total Liabilities And Equity | $5,100 | $0 |